About Nexus Oncology
Nexus Oncology is a company based in Edinburgh (United Kingdom) founded in 1999 was acquired by Chiltern in January 2012.. Nexus Oncology offers products and services including Roundtable Discussions, Video Clips, and Conferences. Nexus Oncology operates in a competitive market with competitors including Helsinn, Aster Insights, CancerVax, Oncotherapeutics and Abogen Biosciences, among others.
- Headquarter Edinburgh, United Kingdom
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nexus Oncology
Nexus Oncology offers a comprehensive portfolio of products and services, including Roundtable Discussions, Video Clips, and Conferences. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Connects experts with oncologists for clinical data updates.
Delivers short videos on latest clinical data via text messages.
Hosts events for advancing oncology knowledge and practices.
Funding Insights of Nexus Oncology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nexus Oncology
Nexus Oncology has secured backing from 1 investor. Prominent investors backing the company include Chiltern. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Full-service oncology CRO operations are conducted globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nexus Oncology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nexus Oncology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nexus Oncology Comparisons
Competitors of Nexus Oncology
Nexus Oncology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helsinn, Aster Insights, CancerVax, Oncotherapeutics and Abogen Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Oncology therapeutics are developed, manufactured, and commercialized by Helsinn.
|
|
| domain | founded_year | HQ Location |
Contract-based oncology clinical trial services are provided by Aster Insights.
|
|
| domain | founded_year | HQ Location |
Cancer vaccine research and development is conducted by CancerVax.
|
|
| domain | founded_year | HQ Location |
Preclinical and clinical oncology drug development services are provided.
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics are developed for cancer and infectious diseases.
|
|
| domain | founded_year | HQ Location |
CRO offering clinical development services for oncology drugs
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Nexus Oncology
When was Nexus Oncology founded?
Nexus Oncology was founded in 1999.
Where is Nexus Oncology located?
Nexus Oncology is headquartered in Edinburgh, United Kingdom. It is registered at Edinburgh, Scotland, United Kingdom.
What does Nexus Oncology do?
Nexus Oncology was founded in 1999 in Edinburgh, United Kingdom, as a contract research organization focused on the oncology sector. Clinical research services were delivered to biopharmaceutical companies for the development of cancer treatments. Drug development programs were designed and implemented across phase I, II, and III oncology trials. The company was acquired by Ockham in February 2012.
Who are the top competitors of Nexus Oncology?
What products or services does Nexus Oncology offer?
Nexus Oncology offers Roundtable Discussions, Video Clips, and Conferences.
Who are Nexus Oncology's investors?
Nexus Oncology has 1 investor. Key investors include Chiltern.